sulfasalazine has been researched along with Scleroderma, Systemic in 6 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Collagenous colitis has been associated with autoimmune diseases." | 1.34 | Collagenous colitis in a patient with systemic sclerosis: a rare entity. ( Coban, S; Ekiz, F; Ensari, A; Gören, D; Ormeci, N; Savas, B, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wada, Y | 1 |
| Kobayashi, D | 1 |
| Murakami, S | 1 |
| Oda, M | 1 |
| Hanawa, H | 1 |
| Kuroda, T | 1 |
| Nakano, M | 1 |
| Narita, I | 1 |
| Ekiz, F | 1 |
| Coban, S | 1 |
| Savas, B | 1 |
| Gören, D | 1 |
| Ensari, A | 1 |
| Ormeci, N | 1 |
| Barnett, AJ | 1 |
| Marks, R | 1 |
| Stáva, Z | 1 |
| Kobíková, M | 1 |
| Greenberger, NJ | 1 |
| Saegh, S | 1 |
| Ruppert, RD | 1 |
| Dover, N | 1 |
6 other studies available for sulfasalazine and Scleroderma, Systemic
| Article | Year |
|---|---|
Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
Topics: Aged; Amyloidosis; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Benzimidazo | 2011 |
Collagenous colitis in a patient with systemic sclerosis: a rare entity.
Topics: Abdomen; Aged; Autoimmune Diseases; Colitis, Collagenous; Comorbidity; Diarrhea; Female; Humans; Lop | 2007 |
Salazopyrin in the treatment of scleroderma.
Topics: Adult; Humans; Male; Middle Aged; Scleroderma, Systemic; Sulfasalazine | 1975 |
Salazopyrin in the treatment of scleroderma.
Topics: Adult; Female; Humans; Male; Middle Aged; Scleroderma, Localized; Scleroderma, Systemic; Sulfasalazi | 1977 |
Urine indican excretion in malabsorptive disorders.
Topics: Celiac Disease; Crohn Disease; Diagnosis, Differential; Feces; Humans; Indican; Intestinal Absorptio | 1968 |
Salazopyrin (azulfidine) treatment in scleroderma.
Topics: Administration, Oral; Adolescent; Adult; Female; Hair; Humans; Male; Middle Aged; Movement; Pigmenta | 1971 |